astrazeneca glp 1 divulges new GLP-1R agonists AstraZeneca’s experimental obesity pill helped
Description
Tirzepatide , sold as Mounjaro for diabetes and Zepbound for weight management, is a dual GLP-1/GIP receptor agonist
Pharmacological interventions, such as glucagon-like peptide-1 (GLP-1) receptor agonists (eg, semaglutide) and dual GLP-1/gastric inhibitory polypeptide receptor agonists (eg, tirzepatide), have led to significant weight loss among users
Handb Exp Pharmacol (2016) 233:43759
Starting with the most worrisome, what exactly is in the product you are about to take
